Timely disclosure｜IR release & Materials｜INVESTOR RELATIONS

IR：ALL

2025.02.12 Timely disclosure	Notice Concerning Succession of Business through Company Split (Simplified Absorption-type Company Split)
2025.01.31 Timely disclosure	Notice Concerning Posting of Extraordinary Income, Income Taxes – Deferred and Revision of First Half and Full Year Consolidated Results Forecasts
2025.01.21 Timely disclosure	Notice Regarding Issuance of New Shares as Restricted Stock Remuneration and Cancellation of Treasury Stock
2024.12.23 Timely disclosure	Notice of Consolidated Subsidiary (Pharmo Inc.)’s Capital Increase Through Third-Party Allotment of Shares
2024.12.23 Timely disclosure	Matters Concerning a Controlling Shareholder, etc.
2024.12.23 Timely disclosure	Notice Concerning Additional Acquisition of Shares in a Consolidated Subsidiary to Make it a Wholly Owned Subsidiary
2024.12.23 Timely disclosure	Notice of Personnel Changes Regarding Officers
2024.12.05 Timely disclosure	Overview of Evaluation Results on the Effectiveness of our Board of Directors
2024.11.22 Timely disclosure	Notice of Personnel Changes Regarding Officers
2024.11.07 Timely disclosure	Notice of differences between financial results and previous results
2024.11.07 Timely disclosure	Notice Concerning Dividend from Surplus
2024.11.07 Timely disclosure	Notice of Concerning Cancellation of Treasury Shares (Cancellation of treasury shares pursuant to the provisions of Article 178 of the Companies Act)
2024.11.07 Timely disclosure	Notice of Personnel Changes Regarding Officers
2024.11.07 Timely disclosure	Notice Concerning Succession of Business through Company Split (Simplified Absorption-type Company Split)
2024.09.19 Timely disclosure	Notice Concerning Succession of Business through Company Split (Simplified Absorption-type Company Split)
2024.08.06 Timely disclosure	Notice of Revision of Full Year Consolidated Results Forecasts
2024.07.19 Timely disclosure	Notice Concerning Absorption-Type Merger (Simplified/Short-Form Merger) of Wholly Owned Subsidiary and Recording of Non-operating income and Extraordinary Losses (Individual Financial Statements)
2024.05.09 Timely disclosure	Notice Concerning Dividend from Surplus (Interim Dividend)
2024.05.07 Timely disclosure	Notice of Revision of First Half (cumulative) and Full Year Consolidated Results Forecasts
2024.02.16 Timely disclosure	Notice Concerning Posting of Extraordinary Income, Income Taxes-Deferred and Revis ion of First Half (cumulative) and Full Year Consolidated Results Forecasts

1 2 … 5 >